(Mayo Clinic 20 July 2016) Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer — a hard-to-detect disease that claims many lives. New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.
Search the blog
SubscribeClick here to subscribe and receive new content by email.
- First 24-hour sexual assault response unit set up in North Queensland abc.net.au/news/2016-07-2… via @ABCNews 1 day ago
- Drug tests may revolutionise Games theaustralian.com.au/sport/new-drug… 2 days ago
- Rachel Antonio inquest findings to be handed down abc.net.au/news/2016-07-2… via @ABCNews 2 days ago
- The Language of #Zika Virus Testing infectioncontrol.tips/2016/07/20/lan… via @PreventionTips 4 days ago
- Qld Police Museum SUNDAY LECTURE: Equipment of today, reflections of the past. mypolice.qld.gov.au/museum/2016/07… 4 days ago
Tags usedAir pollution and analysis Biological and chemical weapons Clinical forensic medicine Clinical pathology Drug analysis and toxicology Environmental toxicology Food science Forensic DNA Forensic pathology Heavy metals / trace elements Hendra virus Influenza Leadership / Management Microbiology Physical evidence Radiation / Health physics Research Science - General Traffic medicine Vector borne diseases Virology Water analysis - biological contamination Water analysis - Non-biological contamination zJournal articles